These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15366429)

  • 1. Effect of the TNF-alpha-promoter polymorphism on cardiac allograft rejection.
    Bedi M; Postava LA; Murali S; MacGowan GA; Mathier M; Shears L; Kormos R; Holubkov R; London B; McNamara DM
    J Heart Lung Transplant; 2004 Jun; 23(6):696-700. PubMed ID: 15366429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of tumor necrosis factor-alpha gene-308 polymorphism on the development of coronary vasculopathy after cardiac transplantation.
    Densem CG; Hutchinson IV; Yonan N; Brooks NH
    J Heart Lung Transplant; 2001 Dec; 20(12):1265-73. PubMed ID: 11744409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy.
    Ternstrom L; Jeppsson A; Ricksten A; Nilsson F
    J Heart Lung Transplant; 2005 Apr; 24(4):433-8. PubMed ID: 15797745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.
    Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR
    Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection.
    Abdallah AN; Cucchi-Mouillot P; Biteau N; Cassaigne A; Haras D; Iron A
    Eur J Immunogenet; 1999 Aug; 26(4):249-55. PubMed ID: 10457886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection.
    Pawlik A; Domanski L; Rozanski J; Florczak M; Dabrowska-Zamojcin E; Dutkiewicz G; Gawronska-Szklarz B
    Transplant Proc; 2005 Jun; 37(5):2041-3. PubMed ID: 15964333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between cytokine gene polymorphisms and kidney allograft survival.
    Pawlik A; Domanski L; Rozanski J; Czerny B; Juzyszyn Z; Dutkiewicz G; Myslak M; Hałasa M; Słojewski M; Dabrowska-Zamojcin E
    Ann Transplant; 2008; 13(2):54-8. PubMed ID: 18566561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver grafts.
    Evans PC; Smith S; Hirschfield G; Rigopoulou E; Wreghitt TG; Wight DG; Taylor CJ; Alexander GJ
    J Hepatol; 2001 May; 34(5):711-5. PubMed ID: 11434617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired kidney graft survival is associated with the TNF-alpha genotype.
    Wramner LG; Norrby J; Hahn-Zoric M; Ahlmén J; Börjesson PA; Carlström J; Hytönen AM; Olausson M; Hanson LA; Padyukov L
    Transplantation; 2004 Jul; 78(1):117-21. PubMed ID: 15257049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients.
    Fernandes H; Koneru B; Fernandes N; Hameed M; Cohen MC; Raveche E; Cohen S
    Transplantation; 2002 Jun; 73(12):1886-91. PubMed ID: 12131682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device.
    Bruggink AH; van Oosterhout MF; De Jonge N; Gmelig-Meyling FH; De Weger RA
    Transpl Immunol; 2008 Apr; 19(1):64-8. PubMed ID: 18346639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alfa and monocyte chemoattractant protein-1 gene polymorphisms in kidney transplant recipients.
    El-Gezawy EM; Eldin EN; Mohamed WS; Mahmoud MS; Saied SA; Abd El-Latif HH; Ibrahim MA
    Saudi J Kidney Dis Transpl; 2013 Jul; 24(4):688-95. PubMed ID: 23816715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased transcript levels of TNF-alpha, TGF-beta, and granzyme B in endomyocardial biopsies correlate with allograft rejection.
    Ramsperger-Gleixner M; Spriewald BM; Tandler R; Kondruweit M; Amann K; Weyand M; Ensminger SM
    Exp Clin Transplant; 2011 Dec; 9(6):387-92. PubMed ID: 22142046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome.
    Awad MR; Webber S; Boyle G; Sturchioĉ C; Ahmed M; Martell J; Law Y; Miller SA; Bowman P; Gribar S; Pigula F; Mazariegos G; Griffith BP; Zeevi A
    J Heart Lung Transplant; 2001 Jun; 20(6):625-30. PubMed ID: 11404167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine gene polymorphism and heart transplant rejection.
    Turner D; Grant SC; Yonan N; Sheldon S; Dyer PA; Sinnott PJ; Hutchinson IV
    Transplantation; 1997 Sep; 64(5):776-9. PubMed ID: 9311720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of TNF alpha and TNF beta gene expression in rat cardiac transplants during allograft rejection.
    Pizarro TT; Malinowska K; Kovacs EJ; Clancy J; Robinson JA; Piccinini LA
    Transplantation; 1993 Aug; 56(2):399-404. PubMed ID: 8356596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of TNF-α, TGF-β1, IL-10, IL-6, and IFN-γ gene polymorphism with acute rejection and infection in lung transplant recipients.
    Mu HJ; Xie P; Chen JY; Gao F; Zou J; Zhang J; Zhang B
    Clin Transplant; 2014 Sep; 28(9):1016-24. PubMed ID: 24974875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
    Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S
    J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study.
    Gendzekhadze K; Rivas-Vetencourt P; Montano RF
    Transpl Immunol; 2006 Nov; 16(3-4):194-9. PubMed ID: 17138053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha-308 G/A polymorphism and acute liver graft rejection: a meta-analysis.
    Liu F; Li B; Wei Y; Ma Y; Yan L; Wen T
    Transpl Immunol; 2010 Oct; 24(1):45-9. PubMed ID: 20888911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.